2022
DOI: 10.1021/jasms.2c00296
|View full text |Cite
|
Sign up to set email alerts
|

Comprehensive Multidimensional Liquid Chromatography–Mass Spectrometry for the Characterization of Charge Variants of a Bispecific Antibody

Abstract: Identification and further characterization of antibody charge variants is a crucial step during biopharmaceutical drug development, particularly with regard to the increasing complexity of novel antibody formats. As a standard analytical approach, manual offline fractionation of charge variants by cation-exchange chromatography followed by comprehensive analytical testing is applied. These conventional workflows are time-consuming and labor-intensive and overall reach their limits in terms of chromatographic … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
10
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 11 publications
(10 citation statements)
references
References 28 publications
0
10
0
Order By: Relevance
“…However, to date, there has been a lack of an analytical workflow dedicated to in-depth characterization of mAb charge variants. Often, analytical efforts are focused on the characterization throughput or new charge variant identification, , but not on comprehensive characterization of mAb charge variants that is needed to sufficiently explain the observed charge heterogeneity. Consequently, the existing workflows relied either on untargeted or targeted peptide mapping analysis.…”
Section: Resultsmentioning
confidence: 99%
“…However, to date, there has been a lack of an analytical workflow dedicated to in-depth characterization of mAb charge variants. Often, analytical efforts are focused on the characterization throughput or new charge variant identification, , but not on comprehensive characterization of mAb charge variants that is needed to sufficiently explain the observed charge heterogeneity. Consequently, the existing workflows relied either on untargeted or targeted peptide mapping analysis.…”
Section: Resultsmentioning
confidence: 99%
“…Importantly, as therapeutic modalities have become more complex, the mass distributions also confirm the correct assembly of the products. For example, native/intact MS is useful for elucidating the correct pairing of bispecific antibodies and the correct assembly of more complex structures. Over the past few decades, the demand for bispecific antibody analysis has increased to thousands of samples per year. New modalities and antibody formats are often developed, leading to a variety of projects for intact mass analysis, which may include light chain ratio optimization, antibody pairing combinations, CDR swapping panels, and purification strategies.…”
Section: Introductionmentioning
confidence: 99%
“…For example, native/intact MS is useful for elucidating the correct pairing of bispecific antibodies and correct assembly of more complex structures. [4][5][6][7] In developing and optimizing bispecific antibody pairing strategies, minimizing undesired species, including mis-paired antibodies and homodimers, is crucial in any bispecific therapeutic platform.…”
Section: Introductionmentioning
confidence: 99%